Filana Therapeutics, Inc. FLNA
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -42.20M | -42.28M | -77.90M | -90.97M | -106.03M |
| Total Depreciation and Amortization | 1.06M | 985.00K | 959.00K | 936.00K | 829.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.99M | 17.92M | 18.43M | 19.58M | 19.95M |
| Change in Net Operating Assets | -4.43M | -5.32M | 28.72M | 38.20M | 1.48M |
| Cash from Operations | -28.58M | -28.70M | -29.79M | -32.25M | -83.77M |
| Capital Expenditure | -553.00K | -602.00K | -581.00K | -581.00K | -137.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -553.00K | -602.00K | -581.00K | -581.00K | -137.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.62M | 0.00 | 0.00 | 90.00K | 1.01M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -329.00K | -396.00K | -380.00K | -329.00K | -- |
| Cash from Financing | 1.29M | -396.00K | -380.00K | -239.00K | 1.01M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -27.84M | -29.70M | -30.76M | -33.07M | -82.90M |